Santa Monica-based nootropics producer TruBrain is expanding into the CBD marketplace with a new product that combines its patent-pending smart drug formula with the increasingly popular hemp extract.
To help finance this expansion, the company launched a crowdfunding campaign that offers an ownership stake in the business to everyday investors. The goal of the campaign, which is hosted on the StartEngine platform, is to raise $1 million in new capital.
Trubrain previously raised $1.6 million from venture capital firms and angel investors, and reached profitability earlier this year, surpassing $12 million in lifetime sales of its cognitive enhancement products.
“Our mission is to help people do their best thinking - that’s why we are excited about CBD," founder and CEO Chris Thompson told Benzinga. "Our preliminary research has shown that CBD has a unique ability to block stress and anxiety, paving the way for TruBrain nootropics to deliver the most dramatic outcomes of mental endurance and break through procrastination.”
Related Links:
NBA Vet Turned Cannabis Exec Al Harrington Talks $16M Funding Round, Social Equity
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!
